Bristol-Myers Squibb completes acquisition of Celgene
After regulatory approval, Bristol-Myers Squibb has announced its successful acquisition of Celgene, completing the merger.
List view / Grid view
After regulatory approval, Bristol-Myers Squibb has announced its successful acquisition of Celgene, completing the merger.
Loss of manufacturing capability as a result of regulatory non-compliance can have a devastating impact on biopharma or medical device manufacturers. In this article, Jenny Yu shares real-life examples from the industry and highlights the downstream effects of these business interruptions.
Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019.
Large-value deals are a new strategy for stakeholders to capitalise on the strengths of other companies and to overcome barriers to financial success.
The British Pharmacopoeia and United States Pharmacopeia partnership is to be formalised to strengthen the quality of medicines and public health.
A treatment for anaemia associated with chronic kidney disease in dialysis patients has been approved in Japan.
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
A new report shows that there is still a lack of female representation within the senior roles of the major pharmaceutical companies.
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
Former FDA Commissioner, Scott Gottlieb, who stepped down from the administration in April, has joined Pfizer’s board of directors.
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
Google and Sanofi have partnered to develop an innovation lab for the advancement of health services.
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.